The prevalence of obesity is rising, becoming a medical problem worldwide. Also GERD incidence is higher in obese patients compared with normal weight, with an increased risk of 2.5 of developing symptoms and erosive esophagitis. Different treatment modalities have been proposed to treat obese patients, but bariatric surgery due to its complex interactions via anatomic, physiologic and neurohormonal changes achieved the best long-term results, with sustained weight loss and decrease of complications and mortality caused by obesity.
INTRODUCTION
Obesity defined by WHO (World Health Organization) as BMI (body mass index) greater than 30 has become an important healthcare issue due to its complications [1] . Approximately 20% of the worldwide population is overweight (BMI > 25) and 10% obese, unfortunately in the next 20 years approximately 2.16 billion people will be overweight and 1.12 billion obese [2] .
Rising rates of obesity have led to an increased incidence of metabolic syndrome, type 2 diabetes mellitus, nonalcoholic fatty liver disease, hyperlipidemia and hypertension [3] . There is a considerable economic burden associated with obesity, with an average of 5% of the total health care cost going toward treating obese patients [4] .
The prevalence of gastroesophageal reflux disease (GERD) and its related disorders is increasing in the United States, Western Europe and Scandinavian countries [5] . The physiopathological explanation is not clear, but there seems to be a direct association between BMI, particularly in the obese range and GERD symptoms (some of the mechanisms involved are lower esophageal sphincter pressure, presence of hiatal hernia -a good predictor of GERD, visceral fat, organomegaly and muscles elasticity responsible for gastroesophageal pressure-gradient).
Lifestyle modifications (low calorie diet and physical exercise) have been successfully used for weight loss for a long period of time, but despite an initial weight loss of typically 5% to 10% in the first 6 months, most weight is unfortunately regained [6, 7] .
Drugs such as orlistat, lorcaserin and phentermine can be an alternative to diet and exercise, but they have an important risk for side effects (pulmonary disorders -pulmonary hypertension or cardiac disorders -valvulopathies) with no substantial weight loss and long term improvement of metabolic syndrome [8, 9] .
Thus, bariatric surgery proved to be the most efficient in achieving significant and sustainable weight loss in severely obese patients, with good results, reducing comorbidities and improving mortality [10] . Bariatric surgery is currently recommended for obese patients defined as BMI (body mass index) higher than 40 or more than 35 with comorbidities (metabolic syndrome, type 2 diabetes mellitus, nonalcoholic fatty liver disease, hyperlipidemia and hypertension, sleep apnea).
The bariatric surgical procedures can be restrictive or malabsorptive. The restrictive bariatric procedures: laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) decrease the functional capacity of the stomach without a notable change in absorption. The malabsorptive-restrictive procedures include Roux-en-Y gastric bypass (RYGB) which is the most common, and biliopancreatic diversion (BPD) [10] .
Laparoscopic adjustable gastric band (LAGB) is a minimally invasive bariatric procedure with rapid patient recovery after procedure, which involves placing an adjustable gastric band around the proximal stomach to divide it into a small pouch and a larger pouch. The inflatable band and of course the size of the pouches can be adjusted via subcutaneous access point as needed, the smaller proximal gastric pouch limits food intake and increases food transit time [11, 12] .
Laparoscopic sleeve gastrectomy (LSG) is a surgical procedure that involves a vertical division on the larger curvature of the stomach, removing a large portion of the body and all of the fundus of the stomach (approximately 25%) to create a smaller gastric pouch. This is a permanent effect, the remaining stomach is stapled closed, and the distal part is normal connected to the small bowel. LSG has a mixt weight loss mechanism, one restrictive and one endocrinologic reducing the level of an appetitestimulating hormone known as ghrelin [13] .
LAGB and LSG do not affect the pyloric sphincter or intestinal absorption of nutrients.
Roux-en-Y gastric bypass (RYGB) is a restrictive-malabsorptive surgical procedure, in which the stomach is cut to form a pouch and a jejunal loop is connected to it. The proximal stomach transection leads to the restrictive effect and the bypassed small bowel with direct connection to the jejunal loop to the malabsorption [14] .
All bariatric surgical procedures have a risk of postprocedural complications like stenosis at anastomotic sites, stomal ulcers, band erosions, and fistulae [15] [16] [17] . Despite anatomic differences, the bariatric procedures have in common alteration of the digestive tract and anatomic rearrangement, phenomena known by the acronim BRAVE: first letter was attributed from bile flow alteration (B), R from the reduction of the stomach size, A from anatomic gut rearrangement and altered flow of nutrients, V for vagal manipulations and E from enteric gut hormone modulation [14, 18] .
Laparoscopic sleeve gastrectomy (LSG) proved to be efficient in weight loss and has gained popularity because of its advantages (simple surgical technique, without intestinal by-pass or anastomosis). Further we will discuss about the morbidity of LSG regarding especially GERD and the mechanisms involved.
METHODS
For this purpose we searched in PubMed for publications studying the effect of laparoscopic sleeve gastrectomy on GERD using the keywords "sleeve gastrectomy" and "gastroesophageal reflux". We selected a number of 20 articles, both prospective and retrospective studies, reviews and meta-analysis.
GERD AND OBESITY
The Montreal Classification defines GERD symptoms as heartburn and regurgitation because of the reflux contents of the stomach in the esophagus, symptoms interfering with physical activity, disturbing sleep, reducing productivity at work. GERD patients have usually altered antireflux mechanisms: LES (lower esophageal sphincter) pressure, phrenicoesophageal ligament, esophageal hiatus of the diaphragm, the angle of His, or physiological changes (esophageal dismotility with poor esophageal clearance, increased acid sensitivity of the esophageal mucosa, high gastric pressure or, rarely, high acid secretion: Zollinger-Ellison syndrome) [19] .
Many studies investigated the connection between high incidence of obesity and GERD. For example, El-Serag et al. point out in a study published in 2005 that obese patients have a 2.5 increased risk of developing reflux symptoms and erosive esophagitis than normal weight people [20] .
Nilsson et al., studying the effect of weight gain, found out that a rise of 3.5 BMI units leads to a 3-fold increased risk in developing new GERD symptoms [21] . In morbidly obese patients some of the pathophysiological mechanisms involved in GERD are: increased transient lower esophageal sphincter relaxations (TLESR), altered esophageal motility with poor esophageal clearance, the presence of hiatal hernia and increased intraabdominal pressure with altered gastroesophageal pressure gradient and delayed gastric emptying [22, 23] . Esophageal dismotility in morbid obesity has a prevalence in the literature varying between 20% to 61% [24, 25] . Some studies have shown that morbidly obese patients may have higher rates of hypotensive LES, but part of them do not have symptoms because of decreased sensation via altered sympathetic and parasympathetic innervations [25] .
Greenstein et al. [26] in a prospective study evaluating obese patients selected for bariatric surgery performed esophageal manometry before operation and revealed varied changes of the esophagus: hypertensive LES (18%), nutcracker esophagus (5%), defective LES (16%), ineffective esophageal disorder (2%), diffuse esophageal spasm (3%), and nonspecific motility disorder (23%). Table 1 summarizes the mechanisms responsible for GERD.
Some behavioral factors may also affect LES pressure independent of the BMI value such as drugs: anticholinergic agents (tricyclic antidepressants, antihistamines), calcium channel antagonist, nitrates, oral contraceptives and estrogen, or food (chocolate, fatty foods, onions, peppermint, garlic), coffee consumption and smoking [5] . Table 1 Mechanisms responsible for GERD GERD in obesity GERD after LSG Improvement of GERD after LSG Increased transient lower esophageal sphincter relaxations (TLESR) [22] LES pressure Reduced acid production Poor esophageal clearance [22, 23] Modifying the angle of His and dissecting of ligaments [30] Reduced gastric volume Hiatal hernia Persistence of hiatal hernia Increased intraabdominal pressure with altered gastroesophageal pressure gradient [22] Increased intraluminal pressure (small gastric pouch and poor compliance) [30] Reduced intraabdominal pressure [30] Mechanism Delayed gastric emptying [23] Narrowing at the junction of the vertical and horizontal parts of the sleeve
Accelerated gastric emptying [30]

LAPAROSCOPIC SLEEVE GASTRECTOMY AND GERD
In the literature the risk of possible complications after LSG is approximately 13%, and the postoperative mortality 0.34% [27] . The majority of complications associated with LSG occur in the late postoperative period: gastroesophageal reflux, stenosis, vomiting, gastric tube stricture, gastrocutaneous fistula and weight regain [28, 29] .
In a review of Chiu et al. from 2011 [30] 4 studies showed high prevalence and 7 studies low prevalence of esophageal reflux after LSG. The explanation for high prevalence of GERD is that LSG influence LES pressure by modifying the angle of His and dissecting of ligaments (see Table 1 ). At the same time, the small gastric pouch has high pressure inside, because of the reduced volume, and is associated with poor gastric compliance and emptying [30] .
Regarding the lower prevalence of GERD after LSG, we must take into account that the weight loss achieved will decrease the abdominal pressure, and another hypothesis is that LSG is associated with accelerated gastric emptying, but this aspect needs further studies in the future. In approximately 3 years postoperatively it seems that the angle of His is restored, and good compliance promotes long-term resolution of GERD [30] .
DuPree CE. et al. [33] in 2014 analyzed the effect of laparoscopic sleeve gastrectomy (LSG) on patients with gastroesophageal reflux disease (GERD) and compared the results of LSG with gastric bypass (GB). From a total of 4832 patients who underwent LSG, 44.5% had preexisting GERD. Of those, 84.1% continued to have GERD symptoms after LSG, with only 15.9% demonstrating GERD resolution. Of LSG with no GERD symptoms preoperative, 8.6% developed de novo GERD postoperatively. In comparison, GB resolved GERD in most patients (62.8%) within 6 months postoperatively (P < .001).
Another study from 2014 made on 71 patients by Rebecchi F et al. [34] showed that LSG improves symptoms and controls the reflux in most morbidly obese patients with preoperative GERD, but the 230 cohort was small. The DeMeester score and total acid exposure (% pH < 4) decreased from 39.5 ± 16.5 to 10.6 ± 5.8, P<0.001; respectively % pH < 4 from 10.2 ± 3.7 to 4.2 ± 2.6, P < 0.001), and "de novo" GERD symptoms occurred in 5.4% patients. Table  2 summarizes the results found for LSG and GERD. 
CONCLUSIONS
We have controversial data regarding LSG and GERD (see Table 2 ), the current studies available showing different results, so further research on this topic is required.
We need more studies to evaluate the effects of LSG on gastrointestinal motility, especially to conclude about the connection with ineffective peristalsis. Esophageal dysmotility (discoordination and alteration of contraction strength or duration) may also lead to gastrointestinal symptoms like heartburn, nausea, vomiting, dysphagia, odynophagia [32] . These correlations were made by Carabotti et al., in their study dysphagia appeared in 19.7% of patients after LSG, manifested as retrosternal discomfort after liquids and solids, and dyspepsia was found at 59.4%, because of high pressure in the small stomach after sleeve [32] , high pressure also linked to the simultaneous gastric and pyloric contractions [38] .
Laparoscopic sleeve gastrectomy leads to stable and adequate weight loss, some data published by Chopra et al. [31] showed high resolution of comorbidities: 84% for diabetes mellitus, 49.99% for hypertension, 90% for asthma, 90.74% for obstructive sleep apnea, and 45.92% for gastroesophageal reflux disease symptoms (GERD), with only six new onsets of GERD symptoms (3.24%).
In conclusion, bariatric surgery has become safer as surgeons gain experience in the evaluation and treatment of obese patients, but careful medical assessment is mandatory before choosing the type of bariatric surgery, especially for those patients who already have GERD. 
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